Age-Related Complement C3 Drives Memory Impairments and Associated Neuropathologies in a Mouse Model

Area of Science:

• Neuroscience
• Immunology
• Aging Research

Background:

• Aging is the primary risk factor for cognitive decline and dementia.
• Molecular changes during aging, including increased complement C3 (C3) levels, are linked to impaired learning and memory.
• Elevated C3 expression is observed in aging brains and in dementia patients, suggesting its role in cognitive deficits.

Purpose of the Study:

• To investigate the causal role of complement C3 (C3) in age-related learning and memory impairments.
• To explore the molecular mechanisms by which C3 elevation affects cognitive function.
• To evaluate the therapeutic potential of targeting C3 for age-related memory deficits.

Main Methods:

• Developed a transgenic mouse model with elevated C3 expression to mimic age-related increases.
• Assessed learning and memory performance in mice with C3 overexpression.
• Utilized quantitative polymerase chain reaction microarray and cellular assays to identify molecular pathways affected by C3.
• Administered antibody therapy targeting C3 in naturally aging SAMP8 mice.

Main Results:

• Transgenic mice with elevated C3 exhibited impaired learning and memory, accompanied by synaptic loss, neuronal loss, and astrocytosis.
• C3 elevation was found to potentially impair cognitive functions by affecting insulin signaling pathways.
• Antibody treatment targeting C3 successfully alleviated learning and memory deficits in SAMP8 mice.

Conclusions:

• Age-related elevation of complement C3 (C3) is a significant driver of memory impairments and associated neuropathologies.
• Targeting C3 presents a promising therapeutic avenue for mitigating age-related cognitive decline and dementia.
• Understanding the link between C3 and insulin signaling pathways may reveal further therapeutic targets.